Sep 2021
GI CONNECT has summarised the highlights of the recent ASCO GI 2018 meeting for you.
Cancers of the lower GI tract by Priv.-Doz. Dr. Thomas Winder, Academic Teaching Hospital Feldkirch, Austria, Swiss Tumor Molecular Institute and University Zurich, Switzerland
Dr Thomas Winder is board certified for haematology and medical oncology. Since January 2020 he has been Head of the Department for Haematology and Oncology at the University Teaching Hospital Feldkirch, Austria. In addition, since 2017 he has been President of the Swiss Tumor Molecular Institute in Zürich Switzerland. Dr Winder’s research focuses on molecular markers to individualize medical treatment of cancer patients. He achieved his expertise in internationally renowned laboratories at University of Southern California, Norris Comprehensive Cancer Center, Los Angeles and University Hospital Zürich, Switzerland. His research activity has been honoured by several national and international awards and high impact publications.
Duration
5 MIN
Downloadable resources
Yes
Download the slides
Language(s)
GI CONNECT update from ASCO GI 2018
Episode 1: Cancers of the lower GI tract Current Episode
Publication
Survey findings presented at ONS 2025 and published in the journal Healthcare
Downloadable 
7 MIN
Apr 2025 
Video
What to know, what to expect, and where to find support
8 MIN
Apr 2025 
Animated Video
Optimising 1st and 2nd line treatment
Downloadable
6 MIN
Apr 2025
Podcast
Optimising precision medicine for improved patient outcomes
Downloadable
26 MIN
Mar 2025
Conference update
A closer look at the evolving treatment landscape
Downloadable
4 MIN
Mar 2025 
Podcast
Experts' insights on treatment strategies in ER+ metastatic breast cancer settings
Downloadable
5 MIN
Mar 2025
